Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers - EurekAlert!
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC - EurekAlert!
Leukemia Breakthrough: Phase III Trial Achieves “Exceptional” Results
